The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The effect of deep AR suppression with enzalutamide or apalutamide on endogenous glucocorticoids: Implications for adverse effects and development of combination therapies.
 
Nima Sharifi
Consulting or Advisory Role - Pfizer
Research Funding - Janssen Oncology
Patents, Royalties, Other Intellectual Property - A patent application has been filed by Cleveland Clinic for a method of steroid-dependent disease treatment based on HSD3B1. Nima Sharifi is a co-inventor on this patent application
 
Mohammad Alyamani
No Relationships to Disclose
 
Jianbo Li
No Relationships to Disclose
 
Mona Patel
No Relationships to Disclose
 
Michael Berk
No Relationships to Disclose
 
Susan Taylor
No Relationships to Disclose
 
Christopher Przybycin
No Relationships to Disclose
 
Edwin M. Posadas
Consulting or Advisory Role - CytoLumina; Genentech/Roche
Speakers' Bureau - Bayer
Research Funding - PFizer
Patents, Royalties, Other Intellectual Property - Patent on NanoVelcro Assay for CTCs in prostate cancer
Travel, Accommodations, Expenses - TRACON Pharma
 
Ravi Amrit Madan
Speakers' Bureau - Boehringer Ingelheim (I); Janssen (I); Pfizer (I)
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Merck (Inst); NantBioScience (Inst); Pfizer (Inst)
 
Brian I. Rini
Leadership - MJH Life Sciences
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; Merck; Peloton Therapeutics; Pfizer; Roche/Genentech; Surface Oncology; synthorx
Research Funding - AstraZeneca/MedImmune (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Pfizer
 
Jorge A. Garcia
Consulting or Advisory Role - Bayer; Clovis Oncology; Eisai; Sanofi; Targeted Oncology
Speakers' Bureau - Bayer; Merck; Sanofi; Sanofi/Aventis
Research Funding - Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (I); Orion (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Clovis Oncology; Eisai; Janssen; Medivation/Astellas; Merck; Sanofi
 
Eric A. Klein
Consulting or Advisory Role - Cellanyx Diagnostics; GRAIL